0001354488-15-005616.txt : 20151222 0001354488-15-005616.hdr.sgml : 20151222 20151222142545 ACCESSION NUMBER: 0001354488-15-005616 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151217 FILED AS OF DATE: 20151222 DATE AS OF CHANGE: 20151222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cellular Biomedicine Group, Inc. CENTRAL INDEX KEY: 0001378624 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 861032927 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: (408) 973-7884 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: EastBridge Investment Group Corp DATE OF NAME CHANGE: 20061019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chan Andrew K CENTRAL INDEX KEY: 0001569877 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36498 FILM NUMBER: 151301818 MAIL ADDRESS: STREET 1: 530 UNIVERSITY AVENUE, #17 CITY: PALO ALTO STATE: CA ZIP: 94301 4 1 issuerdirect_section16.xml PRIMARY DOCUMENT X0306 4 2015-12-17 0 0001378624 Cellular Biomedicine Group, Inc. CBMG 0001569877 Chan Andrew K 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 1 SVP Corp Bus Dev Common Stock 2015-12-17 4 M 0 1516 5.61 A 154461 D Common Stock 2015-12-17 4 S 0 1516 21.28 D 152945 D Common Stock 2015-12-18 4 S 0 10000 22.00 D 142945 D Common Stock 2015-12-21 4 M 0 1296 3.00 A 144241 D Common Stock 2015-12-21 4 S 0 1296 22.26 D 142945 D Non- Qualified Stock Option (right to buy) (2013 Plan) 5.61 2015-12-17 4 M 0 1516 0 D 2023-05-16 Common Stock 1516 42452 D Non- Qualified Stock Option (right to buy) (2011 Plan) 3.00 2015-12-21 4 M 0 1296 0 D 2023-02-20 Common Stock 1296 42759 D The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. The option vested according to the following schedule: 1/31st per month following the vesting commencement date of May 16, 2014. The option vested according to the following schedule: 1/36th per month following the vesting commencement date of February 20, 2013. /s/ Andrew Chan 2015-12-22